WallStreetZenWallStreetZen

NASDAQ: ATXS
Astria Therapeutics Inc Stock Ownership - Who owns Astria Therapeutics?

Insider buying vs selling

Have Astria Therapeutics Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Perceptive Advisors LLCDirector2024-02-012,481,350$12.09
$30.00MBuy
Christopher MorabitoChief Medical Officer2024-01-299,200$3.87
$35.60kBuy
Christopher MorabitoChief Medical Officer2024-01-299,200$11.15
$102.55kSell
Christopher MorabitoChief Medical Officer2024-01-26800$11.02
$8.81kSell
Christopher MorabitoChief Medical Officer2024-01-26800$3.87
$3.10kBuy
Perceptive Advisors LLCDirector2023-12-21740,000$6.20
$4.59MBuy
Perceptive Advisors LLCDirector2023-10-16614,062$6.51
$4.00MBuy
Perceptive Advisors LLCDirector2023-10-16460,546$6.51
$3.00MBuy

1 of 1

ATXS insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ATXS insiders and whales buy or sell their stock.

ATXS Shareholders

What type of owners hold Astria Therapeutics Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Fmr LLC8.75%4,803,025$64.98MInstitution
Perceptive Advisors LLC7.29%4,004,070$54.18MInstitution
Fairmount Funds Management LLC6.47%3,554,129$48.09MInstitution
Vr Adviser LLC5.88%3,225,806$43.65MInstitution
Clarus Lifesciences Ii LP5.01%2,752,488$37.24MInsider
Nicholas Galakatos5.01%2,752,488$37.24MInsider
Vivo Capital LLC4.52%2,482,727$33.59MInstitution
Fred Callori4.51%2,476,924$33.51MInsider
Blackrock Inc3.98%2,184,558$29.56MInstitution
Vanguard Group Inc3.74%2,055,707$27.81MInstitution

1 of 3

ATXS vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ATXS67.13%25.09%Net BuyingNet Buying
ENGN32.55%27.01%Net BuyingNet Buying
ALLO60.41%39.59%Net SellingNet Selling
WVE61.18%38.82%Net Buying
LBPH45.89%0.09%Net SellingNet Selling

Astria Therapeutics Stock Ownership FAQ

Who owns Astria Therapeutics?

Astria Therapeutics (NASDAQ: ATXS) is owned by 67.13% institutional shareholders, 25.09% Astria Therapeutics insiders, and 7.78% retail investors. Clarus Lifesciences Ii LP is the largest individual Astria Therapeutics shareholder, owning 2.75M shares representing 5.01% of the company. Clarus Lifesciences Ii LP's Astria Therapeutics shares are currently valued at $37.43M.

If you're new to stock investing, here's how to buy Astria Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.